Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a joint society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.As more surgeons have access to femtosecond las…
Cataract surgery is usually safe and relatively easy to perform, especially for the experienced eye surgeon. However, the degree of surgical difficulty when performing phacoemulsification often parallels the degree of cataract density that the surgeon …
ALPHARETTA, Ga.–(BUSINESS WIRE)–Clearside Biomedical, a clinical-stage biopharmaceutical company developing drugs for the eye, announces filing of registration statement for proposed Initial Public Offering.
At OSN New York 2015, J. Bradley Randleman, MD, presents the 2015 Waring Medal recipient, named after George O. Waring III, MD, FACS, FRCOphth.
(MedPage Today) — Critics say companies are shifting their costs to the government
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker (NASDAQ: BRKR) today announced that it will webcast its presentation to the investment community at the J.P. Morgan Healthcare Conference on Monday, January 11, 2016, at 1:30 p.m. Pacific Time. To listen to the live webcast, investors can go to http://ir.bruker.com and click on the “Events and Presentations” hyperlink to access the webcast. About Bruker Corporation For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries an